Lab News
FDA shares CDC test with labs on emergency use basis
February 4, 2020 -- In a breakthrough for diagnostics amid the Wuhan coronavirus crisis, the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization paving the way for use at qualified labs of a diagnostic test developed by the U.S. Centers for Disease Control and Prevention (CDC). Read More
Wuhan coronavirus RT-PCR tests deliver results fast
February 4, 2020 -- Scientists in Hong Kong and China have developed rapid reverse transcription polymerase chain reaction (RT-PCR) tests that may be used to identify and confirm the 2019 novel coronavirus (2019-nCoV), with fast results. Their experience with the tests was published in the journal Clinical Chemistry on January 31. Read More
Germany's Genekam rolls out Wuhan coronavirus test
February 4, 2020 -- Genekam Biotechnology has introduced a research-use-only real-time polymerase chain reaction test specific for the novel coronavirus (2019-nCoV) that originated in China and has spread to 24 other countries as of February 4. Read More
Drawbridge's POC HbA1c test cleared for Europe
February 4, 2020 -- The OneDraw single-use, point-of-care (POC) test for hemoglobin A1c (HbA1c) has the CE Mark for sale in European markets, according to its developer, Drawbridge Health, a private company founded by General Electric. Read More
Qiagen brings PIK3CA breast cancer kit to Europe
February 4, 2020 -- Qiagen has announced the European launch of its therascreen polymerase chain reaction kit for detecting PIK3CA mutations in patients with late-stage breast cancer, following receipt of the CE Mark. Read More
Mass spectrometry brings speed, accuracy, specificity to labs
February 3, 2020 -- For years, mass spectrometry found extensive use as a valuable analytical tool in industries ranging from chemical processing to drug discovery and development. Now the technology has transitioned into the clinical lab, with the commercialization of mass spectrometry platforms for microbial identification. Read More
Siemens grows Diagnostics sales, lands Quest deal
February 3, 2020 -- Siemens Healthineers saw strong growth in its Diagnostics business in the first quarter of fiscal 2020, with revenue rising almost 2.6% after currency adjustments. The company also announced an anticipated large order of Atellica Solution immunoassay analyzers by Quest Diagnostics. Read More
Wuhan coronavirus spread may be vastly underestimated
January 31, 2020 -- Up to 75,815 people in the city of Wuhan, China, are estimated to be infected with the 2019 novel coronavirus (2019-nCoV), which is vastly more than official reports, according to a mathematical modeling study by Hong Kong experts that was published online January 31 in the Lancet journal. Read More
Enrichment NGS emerges as surveillance tool for coronavirus
January 31, 2020 -- As the coronavirus continues to grow as a global health concern, researchers are urgently seeking efficient methods to predict and mitigate emerging coronavirus strains. An international team believes that targeted next-generation sequencing (NGS) may be a valuable tool for monitoring both current and future outbreaks. Read More
GenScript launches coronavirus detection test
January 31, 2020 -- Gene synthesis provider GenScript announced the launch of an assay for detecting the novel coronavirus (2019-nCoV) that originated in Wuhan, China, and has spread to more than 20 nations worldwide. Read More
United States and Canadian Academy of Pathology (USCAP) Annual Meeting
March 19-24
Los Angeles, California United States
Nvidia GTC
March 21-24
American College of Cardiology (ACC) Annual Scientific Session and Expo
April 2-4
Washington, DC, District of Columbia United States
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets